HK1051358A1 - N-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, hydrochloride and method of producing the same - Google Patents

N-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, hydrochloride and method of producing the same

Info

Publication number
HK1051358A1
HK1051358A1 HK03103603A HK03103603A HK1051358A1 HK 1051358 A1 HK1051358 A1 HK 1051358A1 HK 03103603 A HK03103603 A HK 03103603A HK 03103603 A HK03103603 A HK 03103603A HK 1051358 A1 HK1051358 A1 HK 1051358A1
Authority
HK
Hong Kong
Prior art keywords
hydrochloride
guanidine
methanesulfonyl
benzoyl
bis
Prior art date
Application number
HK03103603A
Other languages
English (en)
Inventor
Rolf Gericke
Manfred Baumgarth
Hans Markus Bender
Bernhard Ladstetter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HK1051358A1 publication Critical patent/HK1051358A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK03103603A 1999-10-26 2003-05-21 N-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, hydrochloride and method of producing the same HK1051358A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951418A DE19951418A1 (de) 1999-10-26 1999-10-26 Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
PCT/EP2000/009977 WO2001030750A1 (fr) 1999-10-26 2000-10-11 Procede de fabrication de chlorhydrate de n-(4,5-bismethanesulfonyl-2-methyl-benzoyl)-guanidine

Publications (1)

Publication Number Publication Date
HK1051358A1 true HK1051358A1 (en) 2003-08-01

Family

ID=7926842

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03103603A HK1051358A1 (en) 1999-10-26 2003-05-21 N-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, hydrochloride and method of producing the same

Country Status (26)

Country Link
US (1) US6673968B1 (fr)
EP (1) EP1224166B1 (fr)
JP (1) JP4969750B2 (fr)
KR (1) KR100699571B1 (fr)
CN (1) CN1202078C (fr)
AT (1) ATE250026T1 (fr)
AU (1) AU782471B2 (fr)
BR (1) BR0015022A (fr)
CA (1) CA2388915C (fr)
CZ (1) CZ299201B6 (fr)
DE (2) DE19951418A1 (fr)
DK (1) DK1224166T3 (fr)
ES (1) ES2204712T3 (fr)
HK (1) HK1051358A1 (fr)
HU (1) HU228634B1 (fr)
MX (1) MXPA02004144A (fr)
MY (1) MY122651A (fr)
NO (1) NO328250B1 (fr)
PL (1) PL199010B1 (fr)
PT (1) PT1224166E (fr)
RU (1) RU2276134C2 (fr)
SI (1) SI1224166T1 (fr)
SK (1) SK286603B6 (fr)
UA (1) UA73329C2 (fr)
WO (1) WO2001030750A1 (fr)
ZA (1) ZA200204119B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
JP2006525247A (ja) * 2003-05-06 2006-11-09 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング グアニジン塩を結晶化する方法
HUE026025T2 (en) * 2008-05-09 2016-05-30 Merck Patent Gmbh A pharmaceutical composition comprising rimeporide for the treatment of diseases associated with beta cell dysfunction
JOP20200296A1 (ar) * 2013-06-10 2017-06-16 Amgen Inc عمليات صنع وأشكال بلورية من mdm2 مثبط
US9765097B2 (en) * 2014-06-23 2017-09-19 Nissan Chemical Industries, Ltd. Method for producing silane compound having sulfonyl bond
CN108602767A (zh) * 2016-02-08 2018-09-28 默克专利股份有限公司 N-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐酸盐和n-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐的结晶变体
EP3960165A1 (fr) * 2020-08-25 2022-03-02 Fondation EspeRare Inhibiteurs de nhe-1 pour le traitement des infections à coronavirus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216865A (ja) * 1983-05-26 1984-12-06 Mitsui Toatsu Chem Inc システイン塩酸塩水和物の乾燥方法
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0589336T3 (da) * 1992-09-22 1997-06-16 Hoechst Ag Benzylguanidiner, fremgangsmåde til deres fremstilling samt deres anvendelse som antiarytmetika
EP0604852A1 (fr) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 5-Sulfamoylbenzoylguanidines 2,4,N-substituées, comme agents antiarhythmiques, inhibiteurs de la prolifération des cellules, et inhibiteurs de l'écharge sodium-hydrogène
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
ES2139965T3 (es) * 1995-01-30 2000-02-16 Hoechst Ag Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
AU782471B2 (en) 2005-08-04
HUP0203132A2 (hu) 2003-01-28
DE50003759D1 (de) 2003-10-23
NO20021950L (no) 2002-04-25
MXPA02004144A (es) 2006-01-12
EP1224166A1 (fr) 2002-07-24
PL355149A1 (en) 2004-04-05
HUP0203132A3 (en) 2004-12-28
CZ20021354A3 (cs) 2002-09-11
AU1136101A (en) 2001-05-08
BR0015022A (pt) 2002-06-18
EP1224166B1 (fr) 2003-09-17
SI1224166T1 (en) 2004-04-30
CZ299201B6 (cs) 2008-05-14
KR20020044572A (ko) 2002-06-15
ZA200204119B (en) 2003-10-29
CN1202078C (zh) 2005-05-18
ES2204712T3 (es) 2004-05-01
DK1224166T3 (da) 2004-01-05
HU228634B1 (en) 2013-04-29
JP4969750B2 (ja) 2012-07-04
KR100699571B1 (ko) 2007-03-23
PL199010B1 (pl) 2008-08-29
UA73329C2 (uk) 2005-07-15
ATE250026T1 (de) 2003-10-15
MY122651A (en) 2006-04-29
PT1224166E (pt) 2004-02-27
CA2388915A1 (fr) 2001-05-03
SK5462002A3 (en) 2002-10-08
NO20021950D0 (no) 2002-04-25
NO328250B1 (no) 2010-01-18
JP2003512451A (ja) 2003-04-02
CN1382120A (zh) 2002-11-27
DE19951418A1 (de) 2001-05-03
RU2276134C2 (ru) 2006-05-10
CA2388915C (fr) 2009-12-15
US6673968B1 (en) 2004-01-06
WO2001030750A1 (fr) 2001-05-03
SK286603B6 (sk) 2009-02-05

Similar Documents

Publication Publication Date Title
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
HK1023987A1 (en) Sulphinic acid derivatives, method for producing, and their use
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
AU2002224893A1 (en) Method for producing a part and device for carrying out this method
IL154122A0 (en) Crystalline and pure modafinil, and process of preparing the same
ES2104386T3 (es) Compuesto intermedio para la acitromicina.
ATE201203T1 (de) Chirale methylphenyloxazolidinone
IL164516A0 (en) 2,6-Quimolinyl and 2,6-naphthyl derivatives, processes for preparation them and their uses as vla-4 inhibitors
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
HUP0100760A3 (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives, process for producing them and pharmaceutical compositions containing them
RS11304A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
HK1051358A1 (en) N-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, hydrochloride and method of producing the same
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
HK1080077A1 (zh) 非肽的brs-3激動劑
WO2001002350A3 (fr) Nouveaux aminosulfonamides et amidosulfonamides utilises en tant qu'agents antiviraux
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
MXPA04004937A (es) Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
TR200001819T2 (tr) COPD tedavi yöntemi.
ATE242763T1 (de) Methoximinophenylessigsäureamide
HK1027560A1 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
AR026231A1 (es) Proceso para preparar clorhidrato de n-(4,5-bis-metansulfonil-2-metilbenzoil)-guanidina
HU0101721D0 (en) Process for producing of n,n'-carbonil-bis(lactams)
DE60131660D1 (de) Verfahren zur asymetrischen synthese von substituierten 1,4-dihydropyridin-derivaten
PL347584A1 (en) Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors
TH20016A (th) กลูโคไพแรโนไซด์ เบนโซไธโอฟีน

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161011